Senior Scientific Assistant, Genomics & Lab Research

Washington State University; Pullman (WA); On-site; USD 59,000 - 90,000; Full time

Benefits offered by this job

Paid sick leave

Paid vacation leave

Medical, dental, life and disability保险

Retirement plan

Employee tuition waiver

Job summary

Washington State University’s Brayton lab in the College of Veterinary Medicine seeks a Scientific Assistant Senior to support genomics, cell biology, diagnostics, and vaccine development for Anaplasma spp. The role includes DNA work, qPCR, RNA-seq, protein analyses, and animal work; regular lab maintenance and ordering are required.

The position is full-time and temporary, ending September 30, 2027, with potential renewal based on funding.

Qualifications

• Master's degree in a related scientific or engineering discipline with four years of relevant research experience
• PhD may substitute for up to two years of experience
• Five years of professional lab experience preferred
• Ability to design experiments and analyze results; work independently and in a team
• Hands-on knowledge of Anaplasma species or related rickettsias

Responsibilities

• DNA isolation, cloning and sequencing (Sanger and HTS)
• Quantitative PCR and RNA-seq
• Assistance with animal work and gene gun immunization
• Protein analysis (expression, purification, Westerns, ELISAs, IPs, mass spectrometry)
• Yeast library construction; routine lab maintenance and ordering

Skills

Independent work

Experiment design

Data analysis

Anaplasma knowledge

Education

Master's degree

PhD substitution allowed

Tools

SNAPgene

CLC Genomics Workbench

Sanger sequencing

Job description

Washington State University’s Brayton lab in the College of Veterinary Medicine seeks a Scientific Assistant Senior to support genomics, cell biology, diagnostics, and vaccine development for Anaplasma spp. The role includes DNA work, qPCR, RNA-seq, protein analyses, and animal work; regular lab maintenance and ordering are required.

The position is full-time and temporary, ending September 30, 2027, with potential renewal based on funding.